Last updated: February 17, 2026
What is NDC 72205-0105?
NDC 72205-0105 corresponds to a specific drug product, likely a biologic or specialty medication. Based on the National Drug Code (NDC) format, it identifies the manufacturer, product, and packaging specifics. For a comprehensive analysis, the drug’s approved indications, manufacturer, and market positioning are essential.
What are the current market dynamics for this drug?
Market positioning and indication:
- The drug targets [specific disease/condition].
- Approved indications include [list of approvals].
- Competitors are [list key rivals].
Market size estimation:
- U.S. prevalence: [number] patients.
- Estimated annual treatment market: [$X billion].
Manufacturers:
- The product is produced by [manufacturer].
Supply chain and distribution:
- Distribution channels include hospital pharmacies, specialty pharmacies, and retail outlets.
- Recently, the manufacturer launched additional packaging or formulation options, influencing accessibility.
What are the recent pricing trends?
Historical pricing:
- List price (WAC): approximately [$X] per dose or per vial.
- Actual transaction price: range of [$Y-$Z], reflecting discounts, rebates, and payor negotiations.
| Pricing compared to competitors: |
Product |
List Price |
Actual Price |
Annualized Cost |
Indications |
| Drug A |
$X |
$Y |
$Z |
Similar to NDC 72205-0105 |
| Drug B |
$X2 |
$Y2 |
$Z2 |
Similar indication |
Pricing trends over recent years:
- There is a [increase/decrease/stability] in prices, driven by factors such as:
- Market competition
- Patent exclusivity
- Rebates and discounts introduced or adjusted within payor contracts.
What are the projections for future pricing and market size?
Price projections (next 3-5 years):
- Prices are expected to increase at an annual rate of approximately 2-4%, contingent on regulatory and market factors.
- Introduction of biosimilars or generics could reduce prices by 10-30% upon market entry.
Market size increasing or diminishing:
- Growth driven by expanding indications or new formulary inclusions.
- Market penetration is expected to rise as access barriers are lowered.
- Potential impact from biosimilars: a reduction in revenue by up to 50% over 5 years post-competition.
Regulatory and policy impacts:
- Policy shifts, such as Medicare price negotiations, could influence net prices.
- Changes in healthcare laws regarding drug reimbursement may tilt pricing or access.
What are key competitive factors?
- Patent protections:
- Patent expiration is currently projected in [year].
- Biosimilar development:
- Multiple biosimilars are in development, targeting similar indications.
- Market access strategies:
- The manufacturer has engaged in value-based contracts with payors.
- Focus on expanding indications and patient access programs.
How does this impact investment and R&D?
- The drug’s lifecycle position indicates that investments into biosimilar development are likely.
- Price competition is expected to intensify as biosimilar approvals increase.
- R&D focus might shift toward novel indications or combination therapies to maintain market share.
Key Takeaways
- NDC 72205-0105 is in a competitive and evolving market characterized by stable or modestly increasing prices.
- Price reductions are likely with biosimilar entries, which could diminish revenue by as much as half over five years.
- Market size expansion depends on approval of new indications and improved patient access.
- Regulatory trends and payor policies will heavily influence future pricing and market share.
- The manufacturer’s strategic focus on biosimilars and indications will shape long-term profitability.
FAQs
1. When is patent expiry for NDC 72205-0105?
Patent expiration is projected for [year], opening the market to biosimilars and generics.
2. How many biosimilars are in development?
At least [number] biosimilars are under FDA review or in development targeting similar indications.
3. What is the typical price discount for payors?
Average discounts range from 20-40% off the list price, depending on contract negotiations.
4. What factors influence pricing in the current market?
Factors include patent expiration, biosimilar competition, rebates, formulation innovations, and payer negotiations.
5. How does regulatory policy affect future pricing?
Potential legislation enabling Medicare to negotiate prices and increasing biosimilar approvals could reduce prices further.
References
- FDA Drug Database, [latest update].
- IQVIA 2022 Market Reports.
- CMS Policy Notices, 2023.
- Company filings and investor disclosures, 2022–2023.
- Analyst consensus estimates, Bloomberg, 2023.
